NM_000277.2(PAH):c.169G>A (p.Glu57Lys)
Variant summary
The NM_000277.3(PAH):c.169G>A (p.Glu57Lys) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The gene PAH is a tumor suppressor gene (CancerMine: 1 TSG citations). The variant allele was found at a cumulative frequency of 0.0000192 (AC=31) in the gnomAD database across 1,611,646 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.000141. Variant has been reported in ClinVar as Uncertain Significance (★★★). The variant has been observed in cBioPortal in 3 samples across 3 studies and 3 cancer types; somatic enrichment level: SUPPORTING_LOW (Observed in a small number of cBioPortal cases.). This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.
Frequency
Consequence
NM_000277.3 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- classic phenylketonuriaInheritance: AR Classification: DEFINITIVE Submitted by: Natera
- phenylketonuriaInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, G2P, ClinGen, Labcorp Genetics (formerly Invitae), Myriad Women's Health
- maternal phenylketonuriaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- mild hyperphenylalaninemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuriaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Uncertain_significance. The variant received 4 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O6Computational evidence supports deleterious effect | Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer does not indicate an oncogenic effect; O6 not met via missense path; Splice-region variant — splicing algorithms predict an impact on splicing; supports O6 | ||
| O7Mutational hotspot or critical domain | Moderate: ≥10 same AA change, or strong functional domain signal; No cancerhotspots.org hit at this position; UniProt domain: 67 pathogenic, 0 benign (OR vs. background: 675.0).; ±8 AA neighbourhood: 16 pathogenic, 0 benign (OR vs. background: 165.0); No cancerhotspots.org splice hotspot hit at this position | ||
| O8Missense constraint in gene or region | Missense in gene/domain constrained for missense variation where missense is common disease mechanism (O8 supporting); Gene/disease mechanism: missense is a common mechanism of oncogenesis; gnomAD missense Z-score: -0.00 (threshold ≥3.09 for constraint); Domain-level constraint: variant is in a critically constrained functional domain (IS_AT_CRITICAL_DOMAIN) |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000277.3. You can select a different transcript below to see updated classification assignments.
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
PAH | TSL:1MANE Select | c.169G>A p.Glu57Lys | missensesplice_region | Exon 3 of 13 | Prot: ENSP00000448059.1 UniProt: | |
PAH | TSL:1 | n.265G>A | splice_regionnon_coding_transcript_exon | Exon 3 of 6 | Prot: | |
PAH | c.169G>A p.Glu57Lys | missensesplice_region | Exon 3 of 14 | Prot: ENSP00000576754.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 5 sources | |||||
GnomAD3 genomes | AF: 0.00000658 | AC:1 | Hom:0 | AN:152048 | Cov:32 |
GnomAD2 exomes | AF: 0.0000120 | AC:3 | AN:250312 | ||
GnomAD4 exome | AF: 0.0000206 | AC:30 | Hom:0 | AN:1459598 | Cov:29 |
GnomAD4 genome | AF: 0.00000658 | AC:1 | Hom:0 | AN:152048 | Cov:32 |
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.0000774 | AC:2 | Hom:0 | AN:25828 | |
Local & regional cohorts 1 source | |||||
ESP6500 (Exome Variant Server) | AF: 0.0000769 | AC:1 | AN:13006 | ||
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
BipEx | 0.00 | 0 | 28420 | 0.0000347 | 1 | 28844 |
Epi25 | 0.0000238 | 1 | 41958 | 0.0000299 | 2 | 66888 |
SCHEMA | 0.0000193 | 2 | 103362 | 0.0000108 | 2 | 184646 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 25 | |
AlphaMissense | Benign | 0.12 | |
BayesDel_addAF | Pathogenic | 0.23 | D |
BayesDel_noAF | Pathogenic | 0.19 | |
CADD | Pathogenic | 32 | |
DANN | Uncertain | 1.0 | |
DEOGEN2 | Uncertain | 0.79 | D |
Eigen | Benign | 0.019 | |
Eigen_PC | Benign | 0.21 | |
FATHMM_MKL | Pathogenic | 0.97 | D |
FuncVEP CTI | Benign | 0.0065 | |
GPN-Star LLR | N/A | -5.6 | |
GPN-Star score | N/A | 5.6 | |
LIST_S2 | Pathogenic | 0.99 | D |
M_CAP | Pathogenic | 0.65 | D |
MetaRNN | Uncertain | 0.58 | D |
MetaSVM | Pathogenic | 0.94 | D |
Mutation Taster | N/A | 21/79 | disease causing |
MutationAssessor | Benign | 1.4 | L |
PhyloP100 | Uncertain | 5.3 | |
popEVE | Benign | -2.9 | |
PrimateAI | Uncertain | 0.66 | T |
PROVEAN | Benign | -1.5 | N |
REVEL | Uncertain | 0.51 | |
Sift | Benign | 0.32 | T |
Sift4G | Benign | 0.64 | T |
Varity_R | N/A | 0.84 | |
VESM-3B | Benign | -6.9 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
dbscSNV1_ADA | Pathogenic | 1.0 | |
dbscSNV1_RF | Pathogenic | 0.84 | |
DS_AG_spliceai | Pathogenic | 0.64 | Position offset: -3 |
Pangolin (max) | Uncertain | 0.26 | |
Pangolin gain | Uncertain | 0.26 | Position offset: -3 |
SpliceAI score (max) | Pathogenic | 0.64 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.